Sacituzumab govitecan (solution), CAS [[1491917-83-9]]

Produktübersicht

• Artikelname: Sacituzumab govitecan (solution), CAS [[1491917-83-9]]
• Artikelnummer: MCE-HY-132254A
• Hersteller Artikelnummer: HY-132254A
• Alternativnummer: MCE-HY-132254A-100MG,MCE-HY-132254A-5MG,MCE-HY-132254A-1MG,MCE-HY-132254A-25MG,MCE-HY-132254A-50MG,MCE-HY-132254A-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: IMMU-132 (solution)

Produktbeschreibung

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity[1].

Produkteigenschaften

• Reinheit: 99.10
• CAS Nummer: [1491917-83-9]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),TROP2

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related